TrialOpen forum infectious diseases2025
Linezolid-related Optic Nerve Disorders: Insight From a Pharmacovigilance Analysis of the US FDA Adverse Event Reporting System.
Yuki Nakano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.